Certuity’s Ascendis Pharma A/S ASND Stock Holding History

Certuity’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$312K	Hold	1,170	–	–	0.02%	492
2026 Q1	$268K	Hold	1,170	–	–	0.02%	503
2025 Q4	$249K	Buy	1,170 +63	+6%	+$13K	0.02%	483
2025 Q3	$220K	Buy	+1,107	New	+$206K	0.02%	500
2025 Q2	–	Sell	-1,907	Closed	-$297K	–	429
2025 Q1	$297K	Buy	+1,907	New	+$272K	0.03%	269
2024 Q1	–	Sell	-2,144	Closed	-$270K	–	333
2023 Q4	$270K	Buy	+2,144	New	+$214K	0.03%	266

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Certuity's ASND Position: Q2 2026 in Review

Certuity held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 1,170 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #492.

Certuity first reported a position in ASND in Q4 2023 and has held it in 6 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Certuity held 1,170 shares of Ascendis Pharma A/S worth $312K as of Q2 2026.
Certuity left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up 0.02% of Certuity's portfolio in Q2 2026, its #492 holding.
Certuity first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 6 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.